University of Chicago Visiting Professor Series: Hereditary Colon Cancer
Patients with medical conditions of the colon and rectum deliver unique challenges for physicians in general practice. The goal of this activity is to provide physicians and other healthcare professionals with the latest information to be able to provide more effective patient care for these demanding cases.
This activity has been designed to meet the educational needs of physicians and any other healthcare professionals that manage patients with Colorectal Cancer.
At the conclusion of this activity, participants will be able to:
- Identify patients with Lynch Syndrome and Polyposis Syndromes;
- Identify when to refer a patient for hereditary colon cancer genetic counseling;
- Discuss new innovations in surgical and oncological care of individuals at an increased risk of colorectal cancer;
- List hereditary GI cancer risk syndromes;
- Explain the role of genetic counseling and testing for hereditary colorectal cancer;
- Recite the prognostic role of dMMR status in stage II colon cancer;
- Summarize the role of dMMR status in determining treatment for stage II colon cancer;
- Discuss the role of immunotherapy checkpoint inhibitors in patients with dMMR metastatic colon cancer.
Neil H. Hyman, MD
Professor of Surgery
Section Chief, Colon and Rectal Surgery
Co-Director, Digestive Diseases Center
Sonia Kupfer, MD
Assistant Professor of Medicine
Co-Director, Comprehensive Cancer Risk and Prevention Clinic
Blase Polite, MD
Associate Professor of Medicine
Jessica Stoll, MS, CGC
Certified Genetic Counselor
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.